Citius Pharmaceuticals, Inc. Employee Benefits and Share-based Compensation
Citius Pharmaceuticals, Inc. (CTXR) reported Employee Benefits and Share-based Compensation of $2.19 million for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-29.
Discontinued › Notes › Compensation Related Costs › General
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2023-12-29
- Citius Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2023 was $2.19M, a 39.64% increase from fiscal 2022.
- Citius Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2022 was $1.57M, a 41.99% increase from fiscal 2021.
- Citius Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2021 was $1.10M, a 20.77% increase from fiscal 2020.
- Citius Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2020 was $915.00K.
| Period end | Employee Benefits and Share-based Compensation 12 month |
|---|---|
| 2023-09-30 | $2.19M 10-K · filed 2023-12-29 |
| 2022-09-30 | $1.57M 10-K · filed 2023-12-29 |
| 2021-09-30 | $1.10M 10-K · filed 2022-12-22 |
| 2020-09-30 | $915.00K 10-K · filed 2021-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |